Skip to main content
Professor Sean Lim

Professor Sean Lim

Professor of Haematology

Research interests

  • Sean Lim's primary research interest is to understand and develop new immunotherapeutic approaches in cancer. Whilst her clinical expertise lies in lymphoid malignancies her laboratory work also involves solid tumours.
  • Monoclonal antibody therapy
  • Her main research programme focuses on understanding the effects of immunostimulatory monoclonal antibodies in cancer, in particular, how they might be combined with direct, tumour targeting antibodies to induce durable anti-tumour responses.  Her work (Turaj et al Cancer Cell 2017) showed that T cells, when activated by an immunostimulatory antibody against CD27, a TNFR superfamily member, led to bystander activation and infiltration of myeloid cells into the tumour microenvironment.  These myeloid cells had enhanced tumour killing capacity when a second tumour-targeting antibody was given in combination. These preclinical observations were translated into a clinical trial (RiVa) for individuals with relapsed B-cell lymphoma (Lim et al, ASH 2021).  More recently, her laboratory has also characterised how a CD27 monoclonal antibody can be engineered to produce improve immunostimulatory capacity (Heckel et al, Communications Biology 2022). Using single-cell technology, her lab is now focusing on understanding how other immunostimulatory antibodies can be used to manipulate adaptive and innate immunity to induce durable anti-cancer responses.

More research

Accepting applications from PhD students.


Address: Southampton General Hospital, Tremona Road Shirley, SO16 6YD


Sean Lim is Professor of Haematology and Translational Immunology. Her position is funded by a Cancer Research UK Advanced Clinician Scientist Fellowship. This enables her to uniquely bridge the divide between laboratory and clinic. Her research interest is in cancer immunotherapy.

to top